OvaScience, Inc. is a global fertility company. The Company is focused on the discovery, development and commercialization of fertility treatment options for women. The Company's portfolio of fertility treatment options uses its technology, including methods to identify and isolate Egg precursor (EggPC) cells from a patient's own ovarian tissue. The Company's AUGMENT treatment is designed to improve egg health by supplementing a mitochondrial deficiency. With the AUGMENT treatment, energy-producing mitochondria from a patient's own EggPC cells are added to the patient's mature eggs during the in vitro fertilization process to supplement the existing mitochondria. Its OvaPrime treatment is a fertility treatment designed to replenish a woman's ovary by increasing her egg reserve using her own EggPC cells. Its OvaTure treatment is a fertility treatment that seeks to create mature fertilizable eggs in vitro from a woman's own EggPC cells without the need for hormone hyperstimulation.
Industry, Sector and Symbol:
- Sector: Medical
- Industry: Biotechnology
- Sub-Industry: N/A
- Exchange: NASDAQ
- Symbol: OVAS
- Previous Close: $1.48
- 50 Day Moving Average: $1.59
- 200 Day Moving Average: $4.38
- 52-Week Range: $1.30 - $11.66
- Trailing P/E Ratio: N/A
- Foreward P/E Ratio: -0.97
- P/E Growth: 0.00
- Market Cap: $54.12M
- Outstanding Shares: 35,608,000
- Beta: 3.73
- Net Margins: -11,642.67%
- Return on Equity: -62.66%
- Return on Assets: -57.12%
Companies Related to OvaScience:
- Current Ratio: 11.85%
- Quick Ratio: 11.85%
What is OvaScience's stock symbol?
OvaScience trades on the NASDAQ under the ticker symbol "OVAS."
Where is OvaScience's stock going? Where will OvaScience's stock price be in 2017?
6 equities research analysts have issued 1 year price objectives for OvaScience's stock. Their predictions range from $7.00 to $8.83. On average, they expect OvaScience's stock price to reach $7.94 in the next year.
When will OvaScience announce their earnings?
OvaScience is scheduled to release their next quarterly earnings announcement on Thursday, February, 23rd 2017.
Who owns OvaScience stock?
OvaScience's stock is owned by many different of institutional and retail investors. Top institutional investors include FMR LLC (15.00%), Franklin Resources Inc. (1.79%), State Street Corp (1.35%), Third Security LLC (1.05%), Tudor Investment Corp Et Al (0.95%) and Employees Retirement System of Texas (0.25%). Company insiders that own OvaScience stock include Jeffrey E Young, Marc D Kozin, Mary Fisher, Michelle Dipp, Paul WD Chapman and Richard Aldrich.
Who bought OvaScience stock? Who is buying OvaScience stock?
OvaScience's stock was acquired by a variety of institutional investors in the last quarter, including Third Security LLC, Tudor Investment Corp Et Al, FMR LLC and State Street Corp. Company insiders that have bought OvaScience stock in the last two years include Jeffrey E Young, Marc D Kozin, Mary Fisher, Michelle Dipp, Paul WD Chapman and Richard Aldrich.
How do I buy OvaScience stock?
Shares of OvaScience can be purchased through any online brokerage account. Popular online brokerages include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.
How much does a share of OvaScience stock cost?
One share of OvaScience stock can currently be purchased for approximately $1.52.